Correlation between elevated maternal serum alpha-fetoprotein and ischemic placental disease: a retrospective cohort study

References

• Murray MJ, Nicholson JC. Alpha-Fetoprotein. Arch Dis Child Educ Pract Ed. 2011;96(4):141–8. doi:10.1136/adc.2011.213181
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv. 2003;58(12):804–26. doi:10.1097/01.OGX.0000099770.97668.18
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants. Exp Biol Med (Maywood). 2001;226(5):377–408. doi:10.1177/153537020122600503
   PubMed Web of Science ®Google Scholar
• Glowska-Ciemny J, Pankiewicz J, Malewski Z, von Kaisenberg C, Kocylowski R. Alpha-fetoprotein (AFP) - new aspects of a well-known marker in perinatology. Ginekol Pol. 2022;93(1):70–75. doi:10.5603/GP.a2021.0226
   PubMed Web of Science ®Google Scholar
• Wilson RD, Wilson RD, Audibert F, Brock J-A, Campagnolo C, Carroll J, Cartier L, Chitayat D, Gagnon A, Johnson J-A. RETIRED: prenatal screening, diagnosis, and pregnancy management of fetal neural tube defects. J Obstet Gynaecol Can. 2014;36(10):927–39. doi:10.1016/S1701-2163(15)30444-8
   PubMedGoogle Scholar
• Ozturk H, Erkaya S, Altinbas S, Karadag B, Vanli TN, Ozkan D. The role of unexplained high serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in the second trimester to determine poor obstetric outcomes. Turk J Obstet Gynecol. 2014;11(3):142–47. doi:10.4274/tjod.00922
   PubMedGoogle Scholar
• Cohen JL, Smilen KE, Bianco AT, Moshier EL, Ferrara LA, Stone JL. Predictive value of combined serum biomarkers for adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol. 2014;181:89–94. doi:10.1016/j.ejogrb.2014.07.018.
   PubMed Web of Science ®Google Scholar
• Bredaki FE, Matalliotakis M, Wright A, Wright D, Nicolaides KH. Maternal serum alpha-fetoprotein at 12, 22 and 32 weeks’ gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol. 2016;47(4):466–71. doi:10.1002/uog.15818
   PubMed Web of Science ®Google Scholar
• Dinglas C, Afsar N, Cochrane E, Davis J, Kim S, Akerman M, Wells M, Chavez M, Herrera K, Heo H, et al. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease. Am J Obstet Gynecol. 2020;222(5):491–99. doi:10.1016/j.ajog.2019.11.1264.
   Web of Science ®Google Scholar
• Ananth CV. Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption. Semin Perinatol. 2014;38(3):131–32. doi:10.1053/j.semperi.2014.03.001
   PubMed Web of Science ®Google Scholar
• Gu W, Lin J, Hou Y. The value of maternal first and second trimester serum data of beta-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia. Zhonghua Fu Chan Ke Za Zhi. 2015;50(2):101–07.
   PubMedGoogle Scholar
• Celik OY, Obut M, Keles A, Calik MG, Dagdeviren G, Yucel A, Sahin, D. Outcomes of pregnancies diagnosed with circumvallate placenta, and use of uterine artery pulsatility index and maternal serum alpha-fetoprotein for prediction of adverse outcomes. Eur J Obstet Gynecol Reprod Biol. 2021;262:57–61.
   PubMed Web of Science ®Google Scholar
• Odibo AO. Pregnancy associated-plasma protein-A (PAPP-A) and alfa-fetoprotein (AFP) associated with placental abruption. Am J Obstet Gynecol. 2014;211(2):89–90. doi:10.1016/j.ajog.2014.03.062
   PubMed Web of Science ®Google Scholar
• Tancrède S, Bujold E, Giguère Y, Renald M-H, Girouard J, Forest J-C; Tancrede S, Bujold E, Giguere Y, Renald MH, Girouard J, Forest JC. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes. J Obstet Gynaecol Can. 2015;37(2):111–16. doi:10.1016/s1701-2163(15)30331-5.
   PubMed Web of Science ®Google Scholar
• Bredaki FE, Sciorio C, Wright A, Wright D, Nicolaides KH. Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol. 2015;46(1):34–41. doi:10.1002/uog.14809
   PubMed Web of Science ®Google Scholar
• Hu J, Zhang J, He G, Zhu S, Tang X, Su J, Li Q, Kong Y, Zhu B. First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases. BMC Pregnancy Childbirth. 2020;20(1):104. doi:10.1186/s12884-020-2789-2
   PubMed Web of Science ®Google Scholar
• Chinese Medical Association Obstetrics and Gynecology Branch Pregnancy Hypertension Disease Group. Guidelines for Diagnosis and Treatment of Hypertension during Pregnancy (2015). Zhonghua Fu Chan Ke Za Zhi. 2015;50(10):721–28. [Artile in Chinese]
   PubMedGoogle Scholar
• Chinese Medical Association Obstetrics and Gynecology Branch Group. Guidelines for diagnosis and treatment of intrahepatic cholestasis of pregnancy (2015). Zhonghua Fu Chan Ke Za Zhi. 2015;50(7):481–85.
   PubMedGoogle Scholar
• Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva AD, Hod M, Kitzmiler JL, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82. doi:10.2337/dc09-1848.
   PubMed Web of Science ®Google Scholar
• Ehsanipoor R. Premature rupture of membranes: ACOG practice bulletin, number 139. Obstetrics and Gynecology. 2013;122(4):918–30.
   PubMedGoogle Scholar
• Chen Y, Ning W, Wang X, Chen Y, Wu B, Tao J. Maternal hepatitis B surface antigen carrier status and pregnancy outcome: a retrospective cohort study. Epidemiol Infect. 2022;150:1–22. doi:10.1017/S0950268822000681.
   Web of Science ®Google Scholar
• Chen Y, Wang X, Lu S, Huang J, Zhang L, Hu W. The diagnostic accuracy of maternal serum alpha-fetoprotein variants (AFP-L2 and AFP-L3) in predicting fetal open neural tube defects and abdominal wall defects. Clin Chim Acta. 2020;507:125–31. doi:10.1016/j.cca.2020.03.044.
   PubMed Web of Science ®Google Scholar
• Berezowsky A, Pardo J, Ben-Zion M, Wiznitzer A, Aviram A. Second trimester biochemical markers as possible predictors of pathological placentation: a retrospective case-control study. Fetal Diagn Ther. 2019;46(3):187–92. doi:10.1159/000492829
   PubMed Web of Science ®Google Scholar
• Souter VL, Nyberg DA, Benn PA, Zebelman A, Luthardt F, Luthy DA. Correlation of second-trimester sonographic and biochemical markers. J Ultrasound Med. 2004;23(4):505–11. doi:10.7863/jum.2004
   PubMed Web of Science ®Google Scholar
• Blumenfeld YJ, Baer RJ, Druzin ML, El-Sayed YY, Lyell DJ, Faucett AM, Shaw GM, Currier RJ, Jelliffe-Pawlowski LL. Association between maternal characteristics, abnormal serum aneuploidy analytes, and placental abruption. Am J Obstet Gynecol. 2014;211(2):141–44. doi:10.1016/j.ajog
   Web of Science ®Google Scholar
• Obiekwe BC, Malek N, Kitau MJ, Chard T. Maternal and fetal alpha fetoprotein (AFP) levels at term. Relation to sex, weight and gestation of the infant. Acta Obstet Gynecol Scand. 1985;64(3):251–53. doi:10.3109/00016348509155123
   PubMed Web of Science ®Google Scholar
• Bartkute K, Balsyte D, Wisser J, Kurmanavicius J. Pregnancy outcomes regarding maternal serum AFP value in second trimester screening. J Perinat Med. 2017;45(7):817–20. doi:10.1515/jpm-2016-0101
   PubMed Web of Science ®Google Scholar
• Cai Q, Liu H, Han W, Liu L, Xu Y, He Y, Li Q, Zhang M, Hu A, Zheng Y. Maternal HBsAg carriers and adverse pregnancy outcomes: a hospital-based prospective cohort analysis. J Viral Hepat. 2019;26(8):1011–18. doi:10.1111/jvh.13105
   PubMed Web of Science ®Google Scholar
• Joo EJ, Chang Y, Yeom JS, Lee YG, Ryu S. Hepatitis B infection is associated with an increased incidence of thrombocytopenia in healthy adults without cirrhosis. J Viral Hepat. 2017;24(3):253–58. doi:10.1111/jvh.12642
   PubMed Web of Science ®Google Scholar
• Ding Y, Liu K, Xu Y, Zhao Q, Lou S, Xiang X, Yan L, Cao Z, Xie Q, Zhu C, et al. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma. Cancer Med. 2020;9(9):3057–69. doi:10.1002/cam4.2968.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhai Y, Liu H, Li Y, Lu J, Zhang Z. Relationship of mid-trimester serum screening markers and adverse pregnancy outcomes. Zhonghua Yi Xue Za Zhi. 2014;94(5):379–81.
   PubMedGoogle Scholar
• Konchak PS, Bernstein IM, Capeless EL. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels. Am J Obstet Gynecol. 1995;173(4):1115–19. doi:10.1016/0002-9378(95)91336-x
   PubMed Web of Science ®Google Scholar
• Aboughalia H, Bastawrous S, Revzin MV, Delaney SS, Katz DS, Moshiri M. Imaging findings in association with altered maternal alpha-fetoprotein levels during pregnancy. Abdom Radiol (NY). 2020;45(10):3239–57. doi:10.1007/s00261-020-02499-2
   PubMed Web of Science ®Google Scholar
• Dinglas C, Afsar N, Cochrane E, Davis J, Kim S, Akerman M, Wells M, Chavez M, Herrera K, Heo H, et al. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease. Am J Obstet Gynecol. 2020;222(5):491–99. doi:10.1016/j.ajog.2019.11.1264
   Web of Science ®Google Scholar
• Colpaert RM, Ramseyer AM, Luu T, Quick CM, Frye LT, Magann EF. Diagnosis and management of placental mesenchymal disease. a review of the literature. Obstet Gynecol Surv. 2019;74(10):611–22. doi:10.1097/OGX.0000000000000716
   PubMed Web of Science ®Google Scholar
• Morssink LP, de Wolf BT, Kornman LH, Beekhuis JR, van der Hall TP, Mantingh A. The relation between serum markers in the second trimester and placental pathology. A study on extremely small for gestational age fetuses. Br J Obstet Gynaecol. 1996;103(8):779–83. doi:10.1111/j.1471-0528.1996.tb09873.x
   PubMedGoogle Scholar